Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Somatostatinoma 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Insulinoma 2 Glucagonoma 2 Gliosarcoma 2 Gastrinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Islet Cell 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Vipoma 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Solitary Fibrous Tumor, Pleural 1 Primary Myelofibrosis 1 Pheochromocytoma 1

Interventions

lutetium Lu 177 dotatate 40 Everolimus 35 Magnetic Resonance Spectroscopy 15 lanreotide 14 gallium Ga 68 dotatate 13 Temozolomide 13 Octreotide 12 Nivolumab 12 pembrolizumab 11 Capecitabine 11 surufatinib 10 177Lu-octreotide, DOTA(0)-Tyr(3)- 10 cabozantinib 9 Positron Emission Tomography Computed Tomography 9 3-Iodobenzylguanidine 9 Sunitinib 8 Specimen Handling 7 Carboplatin 7 telotristat ethyl 6 pasireotide 6 amino-acid, glucose, and electrolyte solution 6 Somatostatin 6 Lutetium-177 6 90Y-octreotide, DOTA-Tyr(3)- 6 lenvatinib 5 Ipilimumab 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 Etoposide 5 Cisplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroendocrine Tumors × vatalanib × Clear all

NCT00590343 2011-06-29

PTK787

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡